Polarized hyperspectral and polarized light microscopic imaging for enhanced visualization of white blood cells. [PDF]
Zhou X +8 more
europepmc +1 more source
We developed a RhPd‐H nanozyme that integrates enhanced POD‐mimetic catalytic activity with thermally triggered H2 release. H2 shields and reprograms mitochondria to continuously leak endogenous ·O2−. This dual‐path ROS spatially and temporally disrupts redox homeostasis, inducing persistent oxidative stress for tumor suppression and antitumor immunity,
Mingfan Shi +12 more
wiley +1 more source
Future directions in the treatment of brain metastases: evaluating the role of cellular players in the tumour microenvironment. [PDF]
Govaerts CW +3 more
europepmc +1 more source
Engineering Microbial Particles for Next‐Generation Biomedical Platforms
Microbe‐derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus‐like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a ...
Yuting Li +7 more
wiley +1 more source
Predictive Value of Neutrophils, Lymphocytes, Platelets, Neutrophil-Lymphocyte Ratio (NLR), and Platelets-Lymphocyte Ratio (PLR) in Preterm Labor: Single and Combined Indices. [PDF]
Elmaradny E +9 more
europepmc +1 more source
A Recently Recognized and Underdiagnosed Entity of Splenic Diffuse Red Pulp Small B-Cell Lymphoma: A Report of Two Cases. [PDF]
Belkadi S +4 more
europepmc +1 more source
Incomplete B-cell reconstitution in ART-treated people living with HIV is associated with EBV-linked lymphoma progression. [PDF]
Peñaloza N +10 more
europepmc +1 more source
Case Report: Leptomeningeal involvement in chronic lymphocytic leukemia patients with central nervous system infection: extramedullary manifestation or transmigration of leukocytes-how to treat this type of CLL? [PDF]
Zhang T +7 more
europepmc +1 more source
Severe Immune Neutropenia Responsive to Ruxolitinib. [PDF]
Schwarzkopf R +4 more
europepmc +1 more source

